The US Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) from Outlook ...

A study reveals that cryopreserved amniotic membrane enhances recovery and reduces infection risk in post-corneal ...

Apellis Pharmaceuticals recently announced post hoc analysis data of the GALE extension study. This new data is the result of five years of patients continuously treated with SYFOVRE (pegcetacoplan ...